Cover Image

Safety of ivermectin during pregnancy

Saved in:

Bibliographic Details
Main Authors:	Stijn Van Hees (Author), Stephen Raimon (Author), Joseph Nelson Siewe Fodjo (Author), Robert Colebunders (Author)
Format:	Book
Published:	Elsevier, 2020-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

The onchocerciasis hypothesis of nodding syndrome.
by: Robert Colebunders, et al.
Published: (2023)

Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study.
by: Luís-Jorge Amaral, et al.
Published: (2024)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis
by: Patricia Nicolas, MSc, et al.
Published: (2020)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019)

Violence and discrimination among Ugandan residents during the COVID-19 lockdown
by: Elizabeth Katana, et al.
Published: (2021)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

Onchocerciasis-associated epilepsy and biomarkers.
by: Robert Colebunders, et al.
Published: (2024)

Onchocerciasis-associated epilepsy and biomarkers
by: Robert Colebunders, et al.
Published: (2024)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
by: Robert Colebunders, et al.
Published: (2019)

Ivermectin: Evaluation of Efficacy and Safety in COVID-19
by: E. V. Shubnikova, et al.
Published: (2022)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic: Pooled analysis of the International Citizen Project on COVID-19 (ICPCovid) surveys
by: Leonard Ngarka, et al.
Published: (2022)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.
by: Robert Colebunders, et al.
Published: (2021)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
by: Scott McPherson, et al.
Published: (2023)

Ivermectin and the Integrity of Healthcare Evidence During COVID-19
by: Dónal P. O'Mathúna, et al.
Published: (2022)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
by: Nolbert Gumisiriza, et al.
Published: (2020)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
by: Sarah O'Neill, et al.
Published: (2019)

Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
by: Khalfan A Mohammed, et al.
Published: (2008)

Can Ivermectin kill Sarcoptes scabiei during the molting process?
by: Shenrui Feng, et al.
Published: (2023)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
by: Samit Bhattacharyya, et al.
Published: (2023)

Demodex folliculitis of the scalp successfully treated with topical ivermectin
by: Wei-Cheng Fang, et al.
Published: (2021)

COVID-19 outbreak in Brazil: adherence to national preventive measures and impact on people's lives, an online survey
by: Edlaine Faria de Moura Villela, et al.
Published: (2021)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014)

First description of Nodding Syndrome in the Central African Republic.
by: Salvatore Metanmo, et al.
Published: (2021)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013)

Ivermectin worthy of further investigation
by: Andrew C Steer, et al.
Published: (2009)

Identification of the metabolites of ivermectin in humans
by: Phornpimon Tipthara, et al.
Published: (2021)

Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients
by: Marcos Alejandro Mayer, et al.
Published: (2022)

PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile
by: Karen Rowland Yeo, et al.
Published: (2023)

Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial
by: Jose Lenin Beltran Gonzalez, et al.
Published: (2022)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
by: Gasim Abd-Elfarag, et al.
Published: (2018)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
by: Bruno P. Mmbando, et al.
Published: (2018)

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
by: Christoph Kaiser, et al.
Published: (2019)

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers.
by: Jose Muñoz, et al.
Published: (2018)